DRI Healthcare Trust (TO:DHT-U) — Market Cap & Net Worth
Market Cap & Net Worth: DRI Healthcare Trust (DHT-U)
DRI Healthcare Trust (TO:DHT-U) has a market capitalization of $593.86 Million ($593.86 Million) as of May 2, 2026. Listed on the TO stock exchange, this Canada-based company holds position #11661 globally and #331 in its home market, demonstrating a 3.25% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying DRI Healthcare Trust's stock price $12.08 by its total outstanding shares 55500947 (55.50 Million). Analyse DRI Healthcare Trust cash flow conversion to see how efficiently the company converts income to cash.
DRI Healthcare Trust Market Cap History: 2021 to 2026
DRI Healthcare Trust's market capitalization history from 2021 to 2026. Data shows growth from $247.48 Million to $670.45 Million (8.61% CAGR).
DRI Healthcare Trust Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how DRI Healthcare Trust's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.28x
DRI Healthcare Trust's market cap is 3.28 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $247.48 Million | $73.33 Million | $21.56 Million | 3.37x | 11.48x |
| 2022 | $290.13 Million | $79.87 Million | $11.60 Million | 3.63x | 25.02x |
| 2023 | $514.82 Million | $217.98 Million | $92.30 Million | 2.36x | 5.58x |
| 2024 | $458.44 Million | $139.68 Million | -$3.36 Million | 3.28x | N/A |
Competitor Companies of DHT-U by Market Capitalization
Companies near DRI Healthcare Trust in the global market cap rankings as of May 2, 2026.
Key companies related to DRI Healthcare Trust by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #499 globally with a market cap of $52.60 Billion USD.
- Zoetis Inc (NYSE:ZTS): Ranked #525 globally with a market cap of $50.31 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #526 globally with a market cap of $50.29 Billion USD ( CN¥343.70 Billion CNY).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #572 globally with a market cap of $45.88 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #499 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #525 | Zoetis Inc | NYSE:ZTS | $50.31 Billion | $114.16 |
| #526 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $50.29 Billion | CN¥53.88 |
| #572 | GALDERMA GROUP AG | NYSE:GALDY | $45.88 Billion | $42.09 |
DRI Healthcare Trust Historical Marketcap From 2021 to 2026
Between 2021 and today, DRI Healthcare Trust's market cap moved from $247.48 Million to $ 670.45 Million, with a yearly change of 8.61%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $670.45 Million | +5.50% |
| 2025 | $635.49 Million | +38.62% |
| 2024 | $458.44 Million | -10.95% |
| 2023 | $514.82 Million | +77.44% |
| 2022 | $290.13 Million | +17.23% |
| 2021 | $247.48 Million | -- |
End of Day Market Cap According to Different Sources
On May 2nd, 2026 the market cap of DRI Healthcare Trust was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $593.86 Million USD |
| MoneyControl | $593.86 Million USD |
| MarketWatch | $593.86 Million USD |
| marketcap.company | $593.86 Million USD |
| Reuters | $593.86 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About DRI Healthcare Trust
DRI Healthcare Trust focuses on managing and growing a portfolio of pharmaceutical royalties. It owns a portfolio of 18 royalties derived from the sale of 14 various pharmaceutical products that focuses on eight therapeutic areas. The company was incorporated in 2020 and is headquartered in Toronto, Canada.